Nuclidium (private company)
See something wrong or missing? Let us know
Offices:Basel
Business model:B2B
Nuclidium is a Swiss pharma startup developing a copper-based theranostics platform, pairing Copper-61 (for diagnosis) and Copper-67 (for therapy) to address hard-to-treat cancers
Investors:
we tracked 10 investors
You need an account to access this feature. Log in or create one from here.
Do you have a question? Talk to us.
values in USD
Investments 96.77M
You need an account to access this feature. Log in or create one from here.
Do you have a question? Talk to us.
Belgium
Netherlands
Austria
Germany
Denmark
Estonia
Finland
Iceland
Latvia
Lithuania
Norway
Sweden
France
Ireland
Italy
Portugal
Spain
United Kingdom